PD1/IL15 TaCk

N/A

Report date: 2025/02/12 15:59:51

Base Information

Drug NamePD1/IL15 TaCk
Drug Alias NamePD1/IL15 TaCk
ClassificationBiologics
Mechanisms of ActionAnti-PD-1Anti-IL15
TargetsProgrammed cell death protein 1Interleukin-15
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenentech IncXencor Inc
China Registration ClassN/A

Develop Information

Active CompaniesXencor IncGenentech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A